Biohaven's stock slides 15% on deal with Pfizer for its migraine drug Nov. 9, 2021 at 8:07 a.m. ETby Jaimy Lee Biohaven Pharmaceutical stock price target raised to $150 from $101 at BMO Capital Aug. 3, 2021 at 9:20 a.m. ETby Tomi Kilgore ...
Get the latest Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.